| Literature DB >> 35004533 |
Holger Hauch1, Naual El Mohaui1, Johannes E A Wolff2, Vera Vaillant1, Sabine Brill1, Emmanuel Schneck3, Natascha Ströter4, Ulf Sibelius5, Peter Kriwy6, Daniel Berthold5.
Abstract
Introduction: Specialized palliative home care (SPHC) enables children and adolescents with life-limiting illnesses and complex needs to receive care at home. In addition to controlling symptoms and stabilizing the psychosocial situation, crisis anticipation is a component of SPHC. Since the establishment of the reporting SPHC team, parents have called for additional help from emergency medical services (EMS) in emergency situations with unexpected frequency. Children with life limiting diseases could undergo invasive procedures and unhelpful treatments with uncertain consequences. The questions arose as to which factors led to the involvement of the EMS in a palliative situation, what therapy was performed and what outcome could be reached.Entities:
Keywords: cardiopulmonary resuscitation; do-not-resuscitate order; emergency medical service; palliative home care; pediatric emergencies
Year: 2021 PMID: 35004533 PMCID: PMC8727697 DOI: 10.3389/fped.2021.734181
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
SPHC patients with and without EMS responses 2015–2020.
MOS, median overall survival; DNR, Do Not Resuscitate.
Figure 1(A–C) Outcome and characteristics of the patients. (A) There was no difference between the patients' status (alive/deceased) between the EMS and non-EMS group. (B) Most of the patients suffered from neurological diseases and cancer. (C) Patients of the EMS group had a lower but not significant different survival.
Figure 2Influence of distance of the SHPC team to the patients' residency. In the multivariate calculation there is an inverted u-shaped relationship between distance in km and the use of emergency medical services. Up to a value of 32 km, the probability of calling an emergency medical service increases. However, this probability decreases continuously for distances >32 km. = single patient.
Logistic regression (dependent variable 1 = EMS one or more times, 0 = no EMS).
|
| ||
|---|---|---|
| Female (a) | 0.15 | 0.21 |
| Age (in years) | 0.07 | 1.66 |
| ACT1 (b) | 1.73 | 1.81 |
| ACT4 (b) | 1.61 | 1.79 |
| DNR order | −1.81 | −2.12 |
| Migration background | 1.97 | 2.63 |
| Km (ln) | 25.82 | 2.48 |
| Km squared (ln) | −3.61 | −2.51 |
| Cause of death progression palliative causing disease (d) | 0.12 | 0.13 |
| Cause of death complication (d) | 1.68 | 2.04 |
| Population density (low) (e) | 1.02 | 1.25 |
| Days in care (ln) | 0.89 | 3.17 |
| Constant | −54.20 | −2.76 |
|
| 0.00 | |
| Pseudo R-squared | 0.43 | |
| Hosmer-Lemeshow Test | 0.96 | |
| Positive predictive value (dv = 1) | 66.67 | |
| Negative predictive value (dv = 0) | 93.55 | |
|
| 172 |
This figure shows the results of the multivariate logistic regression. Regression coefficients are reported.
p < 0.05;
p < 0.01, (a) Ref.: male, (b) Ref.: ACT 2 & ACT 3, (c) Ref.: care level 1-3, (d) Ref.: still alive, (e) Ref.: middle or high population density (more than 150 people per square kilometer), source: own data, own calculation.
All EMS responses of patients with SPHC treatment.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1 | 1 | F/22 | Low Grade Glioma/ACT-1/(Y, CPR incl. ACLS) | Fall out of bed/(1; A)/III | i.v. analgesia, transport to hospital | Y | Discharge from hospital after 2 days, admission to SPHC treatment |
| 2 | 1 | F/22 | Low Grade Glioma/ACT-1/(Y, CPR, incl. ACLS) | Sudden cardiac arrest, pulseless electrical activity/(3; A)/VII | CPR, ACLS | N | No ROSC, deceased at home, 16 days after first EMS response, suspected pulmonary embolism |
| 3 | 2 | F/13, Twin 1 | Neuronal Ceroid-Lipofuscinosis type 2/ACT-3/(Y, CPR, incl. APLS) | Seizure (status epilepticus)/(3; B, C)/II | Oxygen supplementation, midazolam buccal, waited and transferred to SPHC team | N | Transfer to SPHC, deceased at home 30 days after EMS response |
| 4 | 3 | F/13, Twin 2 | Neuronal Ceroid-Lipofuscinosis type 2/ACT-3/(Y, CPR, incl. APLS) | Suspected pneumonia/(3; B, C)/II | Oxygen supplementation, waited and transferred to SPHC team | N | Transfer to SPHC, deceased at home 42 days after EMS response |
| 5 | 4 | F/5 | Krabbe's disease/ACT-3/ (Y, CPR, BLS, no intubation) | Pneumonia/(3; A)/III | Oxygen supplementation, transport to hospital | Y | Discharge from hospital after 5 days, follow-up SPHC treatment. Patient alive, 10-y old |
| 6 | 5 | F/28 | Mitochondrial disease/ACT-3/(Y, CPR, incl. ACLS) | Sudden cardiac arrest, foreign body aspiration, pulseless electrical activity/(3; A)/VI | CPR, ACLS, ROSC, Transport to hospital | Y | Discharge from hospital after 14 days without further neurological impairment, follow-up SPHC treatment, deceased at home 19 months after EMS response |
| 7 | 6 | F/1 | Low Grade Glioma/ACT-1/(Y, CPR, incl. APLS) | Suspected seizure, not confirmed/(4; A, C)/III | Transport to hospital | Y | Discharge from hospital after 2 days, follow-up SPHC treatment, |
| 8 | 6 | F/1 | Low Grade Glioma/ACT-1/(Y, CPR, incl. APLS) | Suspected bacterial infection, not confirmed/(4, A, C)/III | Transport to hospital | Y | Discharge from hospital after 3 days, follow-up SPHC treatment |
| 9 | 6 | F/1 | Low Grade Glioma/ACT-1/(Y, CPR, incl. APLS) | Suspected bacterial infection, not confirmed/(4, A, C)/III | Transport to hospital | Y | Discharge from hospital after 2 days, follow-up SPHC treatment. Lost to follow-up due to moving |
| 10 | 7 | M/16 | High Grade Glioma/ACT-1/(Y, DNR order) | Seizure/(3, B)/IV | Intravenous application of midazolam, waited and transferred to SPHC team | N | Deceased at home 23 days after EMS response |
| 11 | 8 | F/14 | Mucopolysaccharidosis type 3a/ACT-3/(Y, DNR order) | Seizure/(3, B, C)/IV | Intravenous application of midazolam, transport to hospital | Y | Discharge from hospital after 2 days, follow-up SPHC treatment |
| 12 | 8 | F/14 | Mucopolysaccharidosis type 3a/ACT-3/(Y, DNR order) | Seizure/(3, B, C)/IV | Various intravenous anticonvulsive medications, transport to hospital | Y | Discharge from hospital after 4 days, follow-up SPHC treatment |
| 13 | 8 | F/14 | Mucopolysaccharidosis type 3a/ACT-3/(Y, DNR order) | Seizure/(3, B, C)/III | Transport to hospital | Y | Discharge from hospital after 2 days, follow-up SPHC treatment, patient alive, 19-y old |
| 14 | 9 | M/17 | Hypoxic ischemic encephalopathy (HIE)/ACT-4/(Y, CPR, incl. ACLS) | Family dispute/(4, C)/I | Transport to hospital | Y | Discharge from hospital after 2 days, follow-up SPHC treatment |
| 15 | 9 | M/17 | Hypoxic ischemic encephalopathy/ACT-4/(Y, CPR, incl. ACLS) | Pneumonia/(3, A, C)/V | Oxygen supplementation, transport to hospital | Y | Admission to ICU, invasive ventilation, death in pulmonary failure 5 days after last EMS response |
| 16 | 10 | M/0.8 | Hypoxic ischemic encephalopathy/ACT-4/(Y, full resuscitation, incl. APLS) | Suspected pneumonia/(3, A, C)/III | Oxygen supplementation, transport to hospital | Y | Discharge from hospital after 6 days, follow-up SPHC treatment |
| 17 | 10 | M/0.8 | Hypoxic ischemic encephalopathy/ACT-4/(Y, full resuscitation, incl. APLS) | Bronchitis/(3, A, C)/III | Oxygen supplementation, transport to hospital | Y | Discharge from hospital after 4 days, follow-up SPHC treatment. Lost to follow-up due to stabilization |
| 18 | 11 | M/18 | Leukemia/ACT-1/(Y, DNR order) | Dyspnea (3, B, C)/IV | Oxygen supplementation, waited and transferred to SPHC team | N | Transfer to SPHC, deceased at home 5 days after EMS response |
| 19 | 12 | F/1 | Mitochondrial disease/ACT-3/(Y, full resuscitation, incl. ACLS) | Seizure (3, A, C)/IV | Oxygen supplementation, transport to hospital | Y | Admission to ICU, invasive ventilation, death in pulmonary failure, 14 days after last EMS response |
| 20 | 13 | F/6 | Cardiomyopathy/ACT-1/(Y, full resuscitation, incl. APLS) | Dyspnea (3, C)/IV | Oxygen supplementation, waited and transferred to SPHC team | N | Transfer to SPHC, deceased at home 10 days after EMS response |
| 21 | 14 | F/4 | Unknown syndrome/ACT-4/(Y, full resuscitation, incl. APLS) | Cardiac arrest (3, A, C)/VII | CPR, APLS, waited and transferred to SPHC team for necropsy and psychological crisis intervention | N | No ROSC, deceased at home |
| 22 | 15 | M/13 | Charcot-Marie-Tooth/ACT-4/(Y, full resuscitation, incl. ACLS) | Family dispute/(4, C)/I | waited and transferred to SPHC team | N | Deceased at home 1 day after EMS response |
| 23 | 16 | M/8 | Unknown syndrome/ACT-4/(Y, full resuscitation, incl. APLS) | Pneumonia/(3, A, C)/III | Oxygen supplementation, transport to hospital | Y | Discharge from hospital after 10 days, follow-up SPHC treatment, patient alive, 11-y old |
| 24 | 17 | M/9 | Lennox-Gastaut Syndrome/ACT-4/(Y, DNR order) | Anaphylactic reaction (2, B)/IV | Intravenous application of a steroid, antihistamine drug and epinephrine | Y | Discharge from hospital, follow-up SPHC treatment, patient alive, 11-y old |
| 25 | 18 | F/1 | Atypical Teratoid Rhabdoid Tumor/ACT-1/(Y, full resuscitation, incl. APLS) | Cardiac arrest (3, A, C)/VI | CPR, APLS, transport to hospital | Y | no ROSC, deceased at hospital |
| 26 | 19 | F/1 | Hypoxic ischemic encephalopathy (HIE)/ACT-4/(Y, full resuscitation, incl. APLS) | Suspected pneumonia/(3, A, C)/III | Oxygen supplementation, transport to hospital | Y | Discharge from hospital after 4 days, follow-up SPHC treatment, patient alive, 2-y old |
| 27 | 20 | M/0.4 | Diaphragmatic hernia and lung hypoplasia/ACT-1/(Y, full resuscitation, incl. APLS) | Suspected pneumonia/(3, A, C)/III | Oxygen supplementation, transport to hospital | Y | Discharge from hospital after 3 days. Lost from follow-up due to planned surgery |
Figure 3EMS responses in relation to the absolute patient numbers 2015–2020. There was a low but stable frequency of EMS operations. No reduction or significant changes were detectable in the years 2015–2020.